N-(4,5-Dihydro-1H-iMidazol-2-yl)-6-quinoxalinaMine
-
N-(4,5-Dihydro-1H-iMidazol-2-yl)-6-quinoxalinaMine
structure -
-
CAS No:
91147-43-2
-
Formula:
C11H11N5
-
Chemical Name:
N-(4,5-Dihydro-1H-iMidazol-2-yl)-6-quinoxalinaMine
-
Synonyms:
N-(4,5-Dihydro-1H-iMidazol-2-yl)-6-quinoxalinaMine;Brimonidine Impurity A;Brimonidine EP Impurity A;Brimonidine EP Impurity A (Brimonidine Impurity II);Debromo Brimonidine;Brimonidine Impurity 3;Brimonidine EP Imp A;Brimonidine Impurity 1 (Brimonidine EP Impurity A)
- Categories:
-
CAS No:
N-(4,5-Dihydro-1H-iMidazol-2-yl)-6-quinoxalinaMine Basic Attributes
213.24
213.10144537
5K3E87REH7
DTXSID00436663
N-(4,5-Dihydro-1H-iMidazol-2-yl)-6-quinoxalinaMine Use and Manufacturing
N-(4,5-Dihydro-1H-imidazol-2-yl)-6-quinoxalinamine is an analogue of Brimonidine (B677520), a α2-Adrenoceptor agonist and antiglaucoma agent.
Computed Properties
Molecular Weight:213.24
XLogP3:-0.1
Hydrogen Bond Donor Count:2
Hydrogen Bond Acceptor Count:3
Rotatable Bond Count:2
Exact Mass:213.10144537
Monoisotopic Mass:213.10144537
Topological Polar Surface Area:62.2
Heavy Atom Count:16
Complexity:278
Covalently-Bonded Unit Count:1
Compound Is Canonicalized:Yes
Recommended Suppliers of N-(4,5-Dihydro-1H-iMidazol-2-yl)-6-quinoxalinaMine
-
CN
6 YRS
Business licensed Certified factoryManufactory Supplier of Drospirenone,Tretinoin,Tranexamic acid,Tretinoin,Desogestrel,Diosmin,Isotretinoin,Ambroxol hcl,Brimonidine Tartrate,Bromhexine hcl,Isotretinoin,Dydrogesterone,Sulfacetamide sodium,Minoxidil,Pentosan Polysulfate Sodium,Tosyl chloride,4-Nitrobenzaldehyde,Bakuchiol,D-Chiro Inositol
Learn More Other Chemicals
-
1-(1-BENZOFURAN-3-YL)-2-BROMO-1-ETHANONE
187657-92-7
-
Ethyl oxamate
617-36-7
-
Dapiprazole
72822-12-9
-
Alcaftadine Formula
147084-10-4
-
Brimonidine Formula
59803-98-4
-
Butyl phenyl ether Formula
1126-79-0
-
2-BROMO-6-TERT-BUTYLPYRIDINE Structure
195044-14-5
-
3-Hydroxybenzaldehyde Structure
100-83-4
-
What is (4-Carboxybutyl)triphenylphosphonium bromide
17814-85-6
-
What is (R)-(-)-2-Amino-1-propanol
35320-23-1
Request for Quotation